Manlio Mencoboni
Impact in
-
- Occupational and environmental lung diseases
- Pleural and Pulmonary Diseases
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Lung Cancer Treatments and Mutations
- Medical Imaging and Pathology Studies
- Oncology top 10%
- Lung Cancer Research Studies
- Cancer Immunotherapy and Biomarkers
Papers in
-
- Occupational and environmental lung diseases 22
- Lung Cancer Treatments and Mutations 14
- Oncology 22
- Lung Cancer Research Studies 5
- Neutropenia and Cancer Infections 5
- Cancer Treatment and Pharmacology 5
- Colorectal Cancer Treatments and Studies 4
- Co-authors
- Giovanni Luca Ceresoli (15 shared papers)I Pannacciulli (24 shared papers)Federica Grosso (11 shared papers)Mario Botta (6 shared papers)Antonio Chella (5 shared papers)Marcello Ceppi (5 shared papers)Letizia Gianoncelli (3 shared papers)B. Castagneto (5 shared papers)
In The Last Decade
Manlio Mencoboni
78 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 83
- Pulmonary and Respiratory Medicine 853
- Oncology 280
- Biotechnology 89
- Cancer Research 69
- Genetics 44
Countries citing papers authored by Manlio Mencoboni
This map shows the geographic impact of Manlio Mencoboni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Manlio Mencoboni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Manlio Mencoboni more than expected).
Fields of papers citing papers by Manlio Mencoboni
This network shows the impact of papers produced by Manlio Mencoboni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Manlio Mencoboni. The network helps show where Manlio Mencoboni may publish in the future.
Co-authors
The 25 scholars most cited alongside Manlio Mencoboni, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 79 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 136 | |
| 2 | 2019 | 114 | |
| 3 | 2007 | 103 | |
| 4 | 2008 | 80 | |
| 5 | 2018 | 75 | |
| 6 | 2011 | 72 | |
| 7 | 2013 | 68 | |
| 8 | 2007 | 46 | |
| 9 | 2015 | 40 | |
| 10 | 2004 | 39 | |
| 11 | 2010 | 34 | |
| 12 | 2014 | 29 | |
| 13 | 2021 | 27 | |
| 14 | 2019 | 26 | |
| 15 | Azidothymidine-induced depression of murine hemopoietic progenitor cells. | 1988 | 26 |
| 16 | 1991 | 23 | |
| 17 | 2017 | 23 | |
| 18 | 2018 | 22 | |
| 19 | 2009 | 22 | |
| 20 | 2023 | 20 |
About Manlio Mencoboni
Manlio Mencoboni is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Pathology and Forensic Medicine, Hematology and Immunology, having authored 79 papers that have together received 1.4k indexed citations. Recurring topics across this work include Occupational and environmental lung diseases (22 papers), Lung Cancer Treatments and Mutations (14 papers), Lung Cancer Research Studies (5 papers), Neutropenia and Cancer Infections (5 papers), Cancer Treatment and Pharmacology (5 papers), Cancer Research and Treatments (5 papers), Colorectal Cancer Treatments and Studies (4 papers) and Chemotherapy-induced organ toxicity mitigation (4 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (853 citations), Oncology (280 citations), Biotechnology (89 citations), Cancer Research (69 citations) and Genetics (44 citations). Manlio Mencoboni has collaborated with scholars based in Italy, France and Belgium. Frequent co-authors include Giovanni Luca Ceresoli, I Pannacciulli, Federica Grosso, Mario Botta, Antonio Chella, Marcello Ceppi, Letizia Gianoncelli, B. Castagneto, Armando Santoro and Paolo Andrea Zucali. Their work appears in journals such as Annals of Oncology, Journal of Clinical Oncology, British Journal of Cancer, Chemotherapy and Cancers.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.